Abstract:Argatroban is a peptidomimetic inhibitor of throm bin that is currently undergoing extensive clinical trials as a heparin substitute for thrombotic complications. Argatroban is readily metabolized into a major derivative, M1, that has phar macological characteristics distinct from its parent compound. The currently available clot-based assays measure the cumula tive anticoagulant effect of argatroban and its metabolite(s). Available HPLC methods do not differentiate between argatro ban and M1-metabolite. A modified method was developed to simultaneously quantitate M1-metabolite and argatroban in biological fluids. Initial validation studies for the method in cluded clinical trials of argatroban in patients with heparin- induced thrombocytopenia, (ARG 911 Study) and coronary in terventional procedures (ARG 310 Study). Plasma samples were extracted with acetonitrile and reconstituted in a mobile phase. Calibration curves were prepared by running known standards of argatroban and M1-metabolite in normal human plasma. Ultraviolet detection was made at 320 nm. The reten tion times for argatroban and M1-metabolite peaks were found to be 10.5 ± 0.3 minutes and 3.9 ± 0.1 minutes, respectively. The extraction efficiency was > 95% (r 2 = 0.99). In heparin- induced thrombocytopenia patients with major bleeding com plications (n = 30), the relative increase in M1-metabolite compared to argatroban varied widely (two- to eight-fold). The mean concentration of argatroban during the steady infusion period was found to be 0.7 ± 0.35 μg/mL, and for M1- metabolite, it was 5.5 ± 2.8 μg/mL. Proportionate results were not seen when higher dosages of argatroban were administered (coronary angioplasty studies). Argatroban and M1-metabolite levels also compared well with the results in global clotting assays. Owing to the simultaneous quantitation of argatroban and M1-metabolite, this method provides a rapid assessment of the pharmacokinetics and pharmacodynamics of argatroban. The differential quantitation may be useful in the assessment of relative metabolic turnover of argatroban that can be related to the hepatic and renal functions in a given patient.

Novel crystal form of argatroban and preparation method thereof

Isolation and purification of novel antifungal antibiotic from streptomyces ahygroscopicus

Impact of Crystal Habit on Solubility of Ticagrelor

Preparation and Characterization of Novel Pharmaceutical Co-Crystals: Ticagrelor with Nicotinamide

Exploring the Structural Landscape for a Thrombopoietin Receptor Agonist Avatrombopag Maleate: an Innovative Trihydrate Forms with Improved Solubility Found

Solid-phase Synthesis of Bivalirudin and Its Method Optimization

Baloxavir Marboxil Polymorphs: Investigating the Influence of Molecule Packing on the Dissolution Behavior

Solubility Measurement of Crystal Form II and Form V Ticagrelor in Several Pure Organic Solvents

S-Manidipine hydrochloride crystal form I and preparation method thereof

Separation and Purification of Tricin from an Antioxidant Product Derived from Bamboo Leaves.

Simultaneous Monitoring of Argatroban and Its Major Metabolite Using an HPLC Method: Potential Clinical Applications

Dimemorfan phosphate crystal form II and preparation method thereof, and pharmaceutical composition

Control over Polymorph Formation of Polydatin in Binary Solvent System and Structural Characterization

Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology.

Tuning the physicochemical properties of axitinib by crystallization: Preparation, calculation and Structure-property relationship

Particle design of the metastable form of clopidogrel hydrogen sulfate by building spherulitic growth operating spaces in binary solvent systems

Monitoring the Dissolution Behavior of Novel Pharmaceutical Cocrystals Consisting of Antimalarial Drug Artemisinin with Probe-Type Low-Frequency Raman Spectrometer

Old Polymorph, New Technique: Assessing Ritonavir Crystallinity Using Low-Frequency Raman Spectroscopy

Characterization, crystal structure and stability analysis of dianhydrodulcitol polymorphs

Preclinical Study on a Novel Fluoroderivative of Dabigatran Etexilate in Animal Models

Quantitation of Bivalirudin, a Novel Anticoagulant Peptide, in Human Plasma by LC-MS/MS： Method Development, Validation and Application to Pharmacokinetics